PointofLaw.com
 Subscribe Subscribe   Find us on Twitter Follow POL on Twitter  
   
 
   

 

 

Arkansas drug suit, cont'd



The Chamber's Southeast Texas Record reports that Arkansas AG Dustin McDaniel has hired Houston-based Bailey Perrin Bailey on a 15 percent contingency to go after AstraZeneca, Eli Lilly and Johnson & Johnson, the makers of Seroquel, Zyprexa and Risperdal respectively, for Medicaid damages arising from alleged mismarketing. The hoped-for damages apparently reach $600 million, though that would seem to assume that all sales of the (powerful and highly useful) psychiatric drugs to state purchasers were illegitimate. Earlier: Oct. 4.

Related Entries:

 

 


Isaac Gorodetski
Project Manager,
Center for Legal Policy at the
Manhattan Institute
igorodetski@manhattan-institute.org

Katherine Lazarski
Press Officer,
Manhattan Institute
klazarski@manhattan-institute.org

 

Published by the Manhattan Institute

The Manhattan Insitute's Center for Legal Policy.